Peking University Pharmaceuticals (000788.SZ) released its report for the third quarter of 2024. In the first three quarters, the company achieved revenue...
According to the Zhitong Finance App, Peking University Pharmaceuticals (000788.SZ) released a report for the third quarter of 2024. In the first three quarters, the company achieved revenue of 1.534 billion yuan, a year-on-year decrease of 7.32%. Net profit attributable to shareholders of listed companies was 0.13 billion yuan, an increase of 182.49% year over year. Net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 0.13 billion yuan, an increase of 221.85% over the previous year.
